European journal of radiology · 2026
Lower-Leg muscle index Identifies High-Risk Peripheral artery disease Patients: Mortality prediction via Machine learning.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Zhao Wenxin, Cao Yifan, Guo Yaming, Zhang Xihao, Zhang Bowen, Ren Hongcheng, Chen Zuoguan, Diao Yongpeng, Li Yongjun
Аннотация
RATIONALE AND OBJECTIVES: Sarcopenia is a significant predictor of adverse outcomes in cardiovascular diseases. However, most prior studies have focused on lumbar muscle indices and have overlooked the prognostic relevance of site-specific muscle loss in peripheral artery disease (PAD). This study aimed to evaluate whether machine learning (ML) models incorporating the lower-leg muscle index (LMI) provide superior prediction of long-term mortality in PAD patients undergoing revascularization.
MATERIALS AND METHODS: A retrospective cohort of 208 consecutive PAD patients hospitalized for planned lower-extremity revascularization was analyzed. Preoperative clinical data and CT angiography-derived muscle indices were collected. Feature selection employed LASSO, mRMR, random forest, and gradient boosting; the number of variables was limited by the 10 events per variable rule. Multivariate Cox regression assessed associations between muscle indices and all-cause mortality. Eight ML models were validated, and performance was evaluated with C-index and AUC. Calibration and decision curve analysis were also performed.
RESULTS: During a mean follow-up of 29.5 ± 15.5 months, 44 deaths were recorded. Non-survivors had more comorbidities, inflammation, and lower-limb muscle loss. Among muscle indices, LMI showed the highest discrimination for mortality (AUC 0.71), outperforming abdominal indices. Higher LMI was associated with lower mortality risk (HR = 0.94, 95 % CI 0.92-0.97, p = 0.004) across all subgroups. Gradient boosting yielded the best predictive performance, with C-indexes of 0.847, 0.809, and 0.823 at 1, 3, and 5 years, respectively. Calibration and decision curve analysis demonstrated model robustness and clinical utility.
CONCLUSIONS: Lower-leg muscle index is a superior and accessible predictor of long-term mortality in PAD, exceeding conventional abdominal muscle indices. ML models using LMI enable individualized risk stratification and may improve post-revascularization management.
MATERIALS AND METHODS: A retrospective cohort of 208 consecutive PAD patients hospitalized for planned lower-extremity revascularization was analyzed. Preoperative clinical data and CT angiography-derived muscle indices were collected. Feature selection employed LASSO, mRMR, random forest, and gradient boosting; the number of variables was limited by the 10 events per variable rule. Multivariate Cox regression assessed associations between muscle indices and all-cause mortality. Eight ML models were validated, and performance was evaluated with C-index and AUC. Calibration and decision curve analysis were also performed.
RESULTS: During a mean follow-up of 29.5 ± 15.5 months, 44 deaths were recorded. Non-survivors had more comorbidities, inflammation, and lower-limb muscle loss. Among muscle indices, LMI showed the highest discrimination for mortality (AUC 0.71), outperforming abdominal indices. Higher LMI was associated with lower mortality risk (HR = 0.94, 95 % CI 0.92-0.97, p = 0.004) across all subgroups. Gradient boosting yielded the best predictive performance, with C-indexes of 0.847, 0.809, and 0.823 at 1, 3, and 5 years, respectively. Calibration and decision curve analysis demonstrated model robustness and clinical utility.
CONCLUSIONS: Lower-leg muscle index is a superior and accessible predictor of long-term mortality in PAD, exceeding conventional abdominal muscle indices. ML models using LMI enable individualized risk stratification and may improve post-revascularization management.